Want to bring faster peptide design and streamlined workflows to your team?
Learn more about D360 or contact us for a personalized demo.
Home / Announcement / Peptide Design & Discovery: D360 enhancements make it faster to move from a sequence idea to a prioritized design candidate
The latest release of Certara’s scientific informatics platform, D360 26.5, continues to help discovery teams access, analyze, and visualize molecule and bioactivity data across therapeutic modalities.
Building on the peptide sequence design capabilities introduced earlier, the 26.5 release gives scientists an even stronger toolkit for generating and evaluating peptide ideas within a sequence alignment. This includes:
This update also improves usability with expanded dashboard search, a redesigned Web All Entity details report, direct Excel import, and new equation functions for in-app analysis. On the administration side, D360 26.5 adds configurable Preferred Results for assay queries, a new Client Plugins panel for independently updating sketchers and renderers, and enhancements to authentication and automated testing tools.
Learn more about D360 or contact us for a personalized demo.
Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.